News + Filings Transactions
|
Garber Alan M
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/01/2023 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 44.1k | $19.39 | $854.8k | | 06/01/2023 |
| 02/21/2023 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 40k | $6.30 | $252k | | 02/21/2023 |
| 02/21/2023 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 40k | $17.49 | $699.6k | | 02/21/2023 |
| 05/26/2022 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 42.4k | $18.19 | $771.7k | | 05/26/2022 |
| 05/01/2022 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 4.5k | $276.17 | $1.2M | | 05/01/2022 |
| 03/01/2022 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 40k | $3.13 | $125.2k | | 03/01/2022 |
| 03/01/2022 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 21.3k | $21.00 | $447.3k | | 03/01/2022 |
| 05/27/2021 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 33.5k | $22.48 | $754.2k | | 05/27/2021 |
| 05/01/2021 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 6.1k | $217.20 | $1.3M | | 05/01/2021 |
| 03/15/2021 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 40k | $3.38 | $135.2k | | 03/15/2021 |
| 03/15/2021 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 40k | $23.60 | $944k | | 03/15/2021 |
| 06/01/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 2.3k | $286.27 | $648.1k | | 06/01/2020 |
| 06/01/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Common Stock | 699 | $0.00 | $0 | | 06/01/2020 |
| 05/22/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 36.1k | $24.42 | $881.8k | | 05/21/2020 |
| 05/21/2020 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 30.8k | $24.62 | $757.1k | | 05/21/2020 |
| 02/14/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 12.5k | $21.02 | $262.8k | | 02/14/2020 |
| 01/07/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 87k | $18.01 | $1.6M | | 01/07/2020 |
| 01/07/2020 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 30k | $4.58 | $137.4k | | 01/07/2020 |
| 01/07/2020 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 57k | $5.82 | $331.5k | | 01/07/2020 |
| 06/01/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Common Stock | 1.2k | $0.00 | $0 | | 06/01/2019 |
| 06/01/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 3.3k | $168.04 | $559.6k | | 06/01/2019 |
| 05/23/2019 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 42.6k | $19.77 | $843k | | 05/23/2019 |
| 04/01/2019 | EXELIXIS, INC. | EXEL | Sale | Option (right to buy) | 15k | $5.92 | $88.8k | | 04/01/2019 |
| 04/01/2019 | EXELIXIS, INC. | EXEL | Sale | Option (right to buy) | 15k | $4.57 | $68.6k | | 04/01/2019 |
| 04/01/2019 | EXELIXIS, INC. | EXEL | Exercise | Common Stock | 15k | $5.92 | $88.8k | | 04/01/2019 |
| 04/01/2019 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 15k | $24.00 | $360k | | 04/01/2019 |
| 04/01/2019 | EXELIXIS, INC. | EXEL | Exercise | Common Stock | 15k | $4.57 | $68.6k | | 04/01/2019 |
| 04/01/2019 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 15k | $23.97 | $359.6k | | 04/01/2019 |
| 01/08/2019 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 11.2k | $23.00 | $258.8k | | 01/08/2019 |
| 01/08/2019 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 11.2k | $4.16 | $46.8k | | 01/08/2019 |
| 06/01/2018 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Common Stock | 1.8k | $0.00 | $0 | | 06/01/2018 |
| 06/01/2018 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 3.2k | $152.74 | $493.2k | | 06/01/2018 |
| 05/24/2018 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 31.2k | $20.50 | $638.9k | | 05/24/2018 |
| 04/16/2018 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 15k | $11.66 | $174.9k | | 04/16/2018 |
| 04/16/2018 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 15k | $20.25 | $303.8k | | 04/16/2018 |
|
|